Practice with mock tests, learn from structured notes, and get your questions answered by a global forensic community, all in one place.
Prostate-specific antigen (PSA/p30) and the RSID-Semen immunochromatographic strip are the two principal protein-based confirmatory tests for semen, each with defined sensitivity limits and characteristic behaviour on samples from vasectomised and azoospermic donors.
Last updated:
Finding spermatozoa under the microscope identifies semen definitively, but it fails in a predictable fraction of cases: the donor is azoospermic, the stain is old enough that cells have disappeared, or the sample was washed. Protein-based confirmatory tests fill this gap. Two have become standard across forensic laboratories worldwide: assays for prostate-specific antigen (PSA), historically called p30, and the RSID-Semen strip, which targets semenogelin from the seminal vesicles. Between them, they cover the two main protein secretions of the male reproductive glands, and their results are independent of whether the donor produces sperm.
PSA has a dual identity that sometimes confuses students. In medicine it is a serum marker screened in older men for prostate cancer. In forensic serology it is a seminal plasma protein measured in stain extracts to confirm semen. The numbers involved are vastly different: a man's blood serum might contain 4 nanograms per millilitre in a normal range, while seminal plasma contains 0.5 to 2 milligrams per millilitre, a concentration roughly 100,000-fold higher. That enormous difference is what makes the forensic assay work on heavily diluted stains.
RSID-Semen takes a different route to the same destination. It detects semenogelin I and II, proteins secreted by the seminal vesicles that liquefy the semen coagulum after ejaculation. They are highly specific to semen; no other body fluid produces them at detectable concentrations. This topic covers how both assays work, their published sensitivity limits on aged samples, what happens in azoospermic and vasectomised donors, and the interpretation logic when combining them with acid phosphatase screening and sperm microscopy.
The same protein that fills prostate cancer screening labs is the backbone of forensic semen confirmation.
Prostate-specific antigen was first characterised in forensic serology before oncology discovered its clinical utility. In 1978 George Sensabaugh at the University of California, Berkeley, described a 30-kilodalton protein in seminal plasma that could be used to identify semen stains. He called it p30, after its approximate molecular weight on SDS-PAGE gels. It was not until 1989 that the US Food and Drug Administration approved PSA as a clinical serum marker, and the cross-identification of Sensabaugh's p30 as the same molecule as clinical PSA confirmed that forensic serologists had been detecting prostate-specific antigen for over a decade before the oncology community elevated it to prominence.
The biological basis of its forensic utility is the enormous concentration difference between seminal plasma and all other body fluids. Seminal plasma PSA runs at 0.5 to 2 mg/mL. Male blood serum PSA is in the range of 0.1 to 4 ng/mL in a healthy man. The forensic assay is working at the ng/mL level on diluted stain extracts, which corresponds to seminal plasma diluted millions of times, yet still returns a positive result. This is why PSA-based lateral-flow cards work on items that were washed or that carry only a trace of a stain.
A strip you can run at a crime scene or a bench, with a 10-minute result.
The simplest PSA test format for forensic use is the lateral-flow immunochromatographic strip. The principle is the same as a home pregnancy test: a coloured antibody-conjugate pad at one end of a nitrocellulose membrane is reconstituted with the sample extract; as the liquid front migrates up the membrane, target antigen in the extract is captured by a test-line antibody and forms a visible coloured band. A control line confirms the strip functioned.
| Feature | ABAcard p30 (HemaTrace) | Seratec PSA Semiquant |
|---|---|---|
| Target | PSA (same as p30) | PSA |
| Format | Lateral-flow card, one result line | Lateral-flow strip with semi-quantitative lines |
| Sensitivity (approx.) | 0.2-4 ng/mL of extract | 1 ng/mL reference line |
| Result time | ~10 minutes | ~10 minutes |
| Semi-quantitative? | No (positive/negative) | Yes (3 band-intensity levels) |
| Field portable? | Yes | Yes |
| Common use | Initial triage of items | Comparing fresh vs. aged, estimating stain age |
The ABAcard is the dominant format in North American laboratories. Its sensitivity (limit of detection approximately 0.2-4 ng/mL depending on lot and extraction volume) is well above the concentrations expected from female paraurethral PSA in a vaginal swab taken in the absence of semen. The Seratec PSA Semiquant is more common in European labs and adds the ability to estimate concentration tier by comparing band intensity to the reference line, which some examiners use to assess whether a low-positive result is consistent with diluted semen versus a female-source background.
A second protein source, a second independent line of confirmation.
RSID-Semen (Rapid Stain Identification) was developed by Independent Forensics (Lombard, Illinois) and introduced to forensic practice in the mid-2000s. Its target is semenogelin I and II, proteins produced by the seminal vesicles. Because the seminal vesicles are anatomically and biochemically distinct from the prostate, RSID-Semen and PSA tests report on different biological sources of protein within semen. A stain can be RSID-positive and PSA-positive, or one can be positive while the other has degraded below threshold, which is valuable in aged samples.
The format is a single-use immunochromatographic strip run the same way as the PSA cards. Published validation data show sensitivity in the range of 1:10,000 to 1:100,000 dilution of fresh semen, with positive results on stains aged up to several years under laboratory storage conditions. A validation study by Hartman et al. (2011, published in the Journal of Forensic Sciences) showed RSID-Semen maintained positivity on stained fabrics stored at room temperature for up to 10 years, outperforming some PSA lateral-flow cards on the oldest samples.
How well do these tests hold up on the cases that arrive weeks or years late?
One of the most common questions practitioners ask is how old a stain can be before PSA or RSID-Semen tests return a negative result when semen was genuinely present. Published data give the following picture, which should be treated as a guide rather than a hard cut-off because storage conditions (temperature, humidity, UV exposure) vary enormously between real cases.
| Test | Positive results reported on aged stains | Key limiting factors |
|---|---|---|
| ABAcard p30 (PSA) | Months to several years on fabric stored at room temperature in dark | Heat, humidity, UV light accelerate PSA denaturation |
| Seratec PSA Semiquant | Similar to ABAcard; semi-quantitative signal weakens before becoming negative | Protein hydrolysis in humid conditions |
| RSID-Semen | Up to 10 years in some validation studies on fabric stored dry | Semenogelin more stable than PSA in some substrates; humidity accelerates loss |
| Sperm microscopy (comparison) | Ghost heads: up to months on dry fabric; days in vaginal vault | Enzymatic digestion in body; mechanical loss from fabric |
The practical implication is that a DNA-aged cold-case item often returns positive RSID-Semen results long after sperm microscopy and even PSA tests have gone negative. This is why a complete semen identification battery runs all three: AP screen for triage, PSA for confirmation, RSID for independent confirmation and aged-sample backup. Each adds evidence with a different degradation profile.
The proteins and the sperm come from different places.
A vasectomy severs the vas deferens, preventing sperm from reaching the urethra during ejaculation. It does not affect the prostate or the seminal vesicles, which are the source organs for PSA and semenogelin respectively. Post-vasectomy ejaculate therefore contains both proteins at concentrations that are generally normal or near-normal. Both PSA lateral-flow cards and RSID-Semen will test positive on ejaculate from a successfully vasectomised man.
Non-obstructive azoospermia (the failure to produce sperm due to testicular dysfunction) also does not affect prostatic or seminal vesicle secretion. A man with non-obstructive azoospermia has normal or near-normal seminal plasma protein concentrations with zero spermatozoa. His ejaculate tests AP-positive, PSA-positive, RSID-positive, and sperm-negative on microscopy. This combination is the clearest demonstration that the protein tests are confirming semen (the fluid) rather than just confirming spermatozoa (the cells).
| Donor category | Sperm microscopy | AP test | PSA test | RSID-Semen |
|---|---|---|---|---|
| Normozoospermic (typical) | Positive | Positive | Positive | Positive |
| Post-vasectomy (successful) | Negative | Positive | Positive | Positive |
| Non-obstructive azoospermia | Negative | Positive | Positive | Positive |
| Post-vasectomy with recanalization | Positive (some sperm) | Positive | Positive | Positive |
| No semen deposited | Negative | Possibly (false positive) | Negative (typically) | Negative |
This table is the clearest argument for running both a sperm search and a protein test on every item. The protein tests catch cases the microscopy misses; the microscopy catches degraded samples where proteins have washed out but ghost heads remain. They complement each other because they are detecting different biological components of the same ejaculate.
The strength of a semen identification comes from the weight of several concordant tests, not one dramatic result.
No single test confirms semen in isolation. Each test has a sensitivity floor below which it cannot detect, and each has rare false-positive or false-negative scenarios. The standard practice in accredited forensic laboratories is to apply multiple tests to a positive screen result, interpret them as a battery, and report the combined strength of the identification.
Reporting language matters. 'Semen detected' or 'semen identified' should be reserved for cases where a semen-specific confirmatory test (not just AP) is positive. 'Consistent with semen' or 'presumptive positive for semen' is appropriate for an AP-only positive. The distinction affects how the result is interpreted in court.
Sometimes a strip result is not enough and a number is needed.
Lateral-flow cards give a qualitative or semi-quantitative result. In some casework scenarios, a quantitative PSA value by ELISA is useful: when the question is whether a very low-level positive on a lateral-flow strip is semen-derived or a female background; when a case involves a suspected mix of body fluids and the question is relative contributions; or when an expert needs to compare PSA concentrations across multiple items from the same case.
Standard clinical ELISA kits originally designed for oncology PSA measurement are used in forensic laboratories after internal validation. The extract is run at multiple dilutions against a calibration curve. A result above the laboratory's validated threshold (commonly 0.5 ng/mL or higher) in a stain extract from a sexual assault item is interpreted as semen-positive. Below-threshold results are reported as PSA not detected at this threshold, not as semen-negative, to avoid overstating a negative conclusion.
What is the relationship between p30 and PSA in forensic serology?
Test yourself on Forensic Serology with free, timed mocks.
Practice Forensic Serology questionsSpotted an error in this page? Report a correction or read our editorial standards.